Literature DB >> 18316232

Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005.

Gianluca Trifirò1, Rodolfo Savica, Letterio Morgante, Nicola Vanacore, Michele Tari, Salvatore Moretti, Mariella Galdo, Edoardo Spina, Achille P Caputi, Vincenzo Arcoraci.   

Abstract

Aim of this study was to evaluate prevalence of use and prescribing pattern of Anti-Parkinson Drugs (APDs) in general practice of Southern Italy. Among 120,000 individuals registered in the lists of 93 general practitioners of Southern Italy, we estimated one-year prevalence and incidence of APD use in the years 2003-2005. Overall, prevalence of APD use remained stable over the years and it strongly increased in subjects over 70 years of age. L-Dopa with a dopa decarboxylase inhibitor was the most frequently prescribed APD, although the use of both ergot and non-ergot derivative DAs has increased, particularly, in the elderly. A high proportion of APD users (15-20%) received only one prescription during the study period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316232     DOI: 10.1016/j.parkreldis.2007.10.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  15 in total

1.  Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.

Authors:  Rosarita Ferrara; Valentina Ientile; Vincenzo Arcoraci; Carmen Ferrajolo; Carlo Piccinni; Andrea Fontana; Salvatore Benvenga; Gianluca Trifirò
Journal:  Endocrine       Date:  2017-02-02       Impact factor: 3.633

2.  Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy.

Authors:  Domenico Italiano; Elisa Bianchini; Maura Ilardi; Roberto Cilia; Gianni Pezzoli; Renzo Zanettini; Laura Vacca; Fabrizio Stocchi; Placido Bramanti; Rosella Ciurleo; Giuseppe Di Lorenzo; Giovanni Polimeni; Cynthia de Luise; Douglas Ross; Peter Rijnbeek; Miriam Sturkenboom; Gianluca Trifirò
Journal:  J Neural Transm (Vienna)       Date:  2014-09-18       Impact factor: 3.575

3.  Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis.

Authors:  Sachiko Kasamo; Masato Takeuchi; Masashi Ikuno; Yohei Kawasaki; Shiro Tanaka; Ryosuke Takahashi; Koji Kawakami
Journal:  J Neurol       Date:  2019-05-10       Impact factor: 4.849

4.  Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.

Authors:  Domenico Italiano; Annalisa Capuano; Angela Alibrandi; Rosarita Ferrara; Angelo Cannata; Gianluca Trifirò; Janet Sultana; Carmen Ferrajolo; Michele Tari; Daniele Ugo Tari; Margherita Perrotta; Claudia Pagliaro; Concita Rafaniello; Edoardo Spina; Vincenzo Arcoraci
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

5.  Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Manuela Tabali; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Geriatr       Date:  2010-07-21       Impact factor: 3.921

6.  Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.

Authors:  Ylenia Ingrasciotta; Janet Sultana; Francesco Giorgianni; Andrea Fontana; Antonio Santangelo; Daniele Ugo Tari; Domenico Santoro; Vincenzo Arcoraci; Margherita Perrotta; Luisa Ibanez; Gianluca Trifirò
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

7.  Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Authors:  James A G Crispo; Yannick Fortin; Dylan P Thibault; Matthew Emons; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald Mattison; Allison W Willis; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2015-06-18       Impact factor: 2.953

8.  Prevalence and Correlates of Anti-Parkinson Drug Use in a Nationally Representative Sample.

Authors:  Nabila Dahodwala; Allison W Willis; Pengxiang Li; Jalpa A Doshi
Journal:  Mov Disord Clin Pract       Date:  2016-08-22

9.  Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors.

Authors:  Caroline D Binde; Ingunn F Tvete; Marianne Klemp
Journal:  Parkinsons Dis       Date:  2021-07-01

10.  The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy.

Authors:  Ylenia Ingrasciotta; Janet Sultana; Francesco Giorgianni; Achille Patrizio Caputi; Vincenzo Arcoraci; Daniele Ugo Tari; Claudio Linguiti; Margherita Perrotta; Andrea Nucita; Fabio Pellegrini; Andrea Fontana; Lorenzo Cavagna; Domenico Santoro; Gianluca Trifirò
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.